These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7961063)

  • 1. Bluetongue virus: contamination of vaccine.
    O'Toole D; Van Campen H; Woodard L
    J Am Vet Med Assoc; 1994 Aug; 205(3):407-8. PubMed ID: 7961063
    [No Abstract]   [Full Text] [Related]  

  • 2. Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus.
    Wilbur LA; Evermann JF; Levings RL; Stoll IR; Starling DE; Spillers CA; Gustafson GA; McKeirnan AJ
    J Am Vet Med Assoc; 1994 Jun; 204(11):1762-5. PubMed ID: 8063596
    [No Abstract]   [Full Text] [Related]  

  • 3. Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus.
    Levings RL; Wilbur LA; Evermann JF; Stoll IR; Starling DE; Spillers CA; Gustafson GA; McKeiman AJ; Rhyan JC; Halverson DH; Rosenbusch RF
    Dev Biol Stand; 1996; 88():219-20. PubMed ID: 9119141
    [No Abstract]   [Full Text] [Related]  

  • 4. Contamination of a live virus vaccine against pseudorabies (Aujeszky's disease) by an ovine pestivirus pathogen for the pig.
    Vannier P; Leforban Y; Carnero R; Cariolet R
    Ann Rech Vet; 1988; 19(4):283-90. PubMed ID: 2852911
    [No Abstract]   [Full Text] [Related]  

  • 5. Bluetongue disease in dogs associated with contaminated vaccine.
    Akita GY; Ianconescu M; MacLachlan NJ; Osburn BI
    Vet Rec; 1994 Mar; 134(11):283-4. PubMed ID: 8197702
    [No Abstract]   [Full Text] [Related]  

  • 6. Canine fatalities associated with the use of a modified live vaccine administered during late stages of pregnancy.
    Evermann JF; McKeirnan AJ; Wilbur LA; Levings RL; Trueblood ES; Baldwin TJ; Hughbanks FG
    J Vet Diagn Invest; 1994 Jul; 6(3):353-7. PubMed ID: 7948206
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
    Hunter P; Modumo J
    Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bluetongue virus 'assembly kit' offers hope for improved vaccines.
    Vet Rec; 2011 Aug; 169(6):138. PubMed ID: 21821679
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of bluetongue virus in tissues of experimentally infected pregnant dogs as determined by in situ hybridization.
    Brown CC; Rhyan JC; Grubman MJ; Wilbur LA
    Vet Pathol; 1996 May; 33(3):337-40. PubMed ID: 8740708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bluetongue virus infection in pregnant ewes.
    Parsonson IM; Luedke AJ; Barber TL; Walton TE
    Am J Vet Res; 1994 May; 55(5):666-9. PubMed ID: 8067615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bluetongue virus serotype 8 (BTV-8)-associated brain malformations in two calves].
    Peters M; Mösenfechtel S; Jacobsen B; Beineke A; Wohlsein P
    Dtsch Tierarztl Wochenschr; 2008 Aug; 115(8):298-303. PubMed ID: 18717057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination in the control of bluetongue in endemic regions: the South African experience.
    Dungu B; Potgieter C; Von Teichman B; Smit T
    Dev Biol (Basel); 2004; 119():463-72. PubMed ID: 15742661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bluetongue vaccines.
    Noad R; Roy P
    Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.
    Ferrari G; De Liberato C; Scavia G; Lorenzetti R; Zini M; Farina F; Magliano A; Cardeti G; Scholl F; Guidoni M; Scicluna MT; Amaddeo D; Scaramozzino P; Autorino GL
    Prev Vet Med; 2005 May; 68(2-4):103-13. PubMed ID: 15820110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
    Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
    Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.